Biopharmaceutical Research Company

BRC Therapeutics develops safe, non-addictive cannabinoid-based medicines targeting pain and neurological conditions. With a focus on regulated, DEA-compliant therapeutics, they are advancing clinical trials for Complex Regional Pain Syndrome and Aromatase Inhibitor-Induced Arthralgia, aiming to improve patient quality of life through innovative, multimodal treatments.